News & Perspective

(CIDRAP News) – Experts are puzzled by a new study in which influenza vaccination seemed to provide little or no protection against flu in the 2010-11 season—and in which the only participants who seemed to benefit from the vaccine were those who hadn't been vaccinated the season before.

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

(CIDRAP News) – A recent editorial calling for requiring influenza shots in healthcare workers (HCWs) has stirred debate in the pages of the Canadian Medical Association Journal (CMAJ), with two groups of researchers questioning the quality of the evidence that the vaccinations protect patients.

Editor’s Note: This article covers research conducted by CIDRAP scientists. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

Disclosure: The University of Minnesota's Center for Infectious Disease Research and Policy, which publishes CIDRAP News, has produced training programs and materials for the BioWatch program. The news team has no involvement in the center's BioWatch work.

In the wake of a newspaper investigation that questioned the value of the federal BioWatch program for detecting dangerous airborne pathogens, some public health officials familiar with the program acknowledge that it's far from perfect, but they say it's not time to scrap it.

(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.

(CIDRAP News) – The controversy over research about potentially dangerous H5N1 viruses heated up last night in a New York City debate that featured some of the leading voices exchanging blunt comments on the alleged risks and benefits of publishing or withholding the full details of the studies.

(CIDRAP News) – The battle over dissemination of controversial research on mutant H5N1 avian influenza viruses continued in a flurry of commentaries and media letters in recent days, covering the full range of issues from the potential public health benefits to scientific censorship and the risk of bioterrorist exploitation of the findings.